4//SEC Filing
Norstrud Andrew James 4
Accession 0001181431-10-008924
CIK 0001360479other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 7:37 AM ET
Size
5.4 KB
Accession
0001181431-10-008924
Insider Transaction Report
Form 4
Norstrud Andrew James
DirectorChief Financial Officer
Transactions
- Award
Option
2010-01-04$0.11/sh+500,000$55,000→ 1,800,000 totalExercise: $0.11From: 2010-01-04Exp: 2020-01-04→ Common Stock (500,000 underlying)
Documents
Issuer
Stem Cell Therapy International, Inc.
CIK 0001360479
Entity typeother
Related Parties
1- filerCIK 0001311402
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 7:37 AM ET
- Size
- 5.4 KB